[Clinical features and diagnosis of langerhans cell hyperplasia]

Kong Zhang1, Hui Zeng, Wei-Qi Chen

  • 1Department of Internal Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, P. R. China. zswgzx@sohu.com

Insights

Langerhans cell hyperplasia (LCH) is increasingly diagnosed, often presenting with diverse symptoms leading to misdiagnosis. Early diagnosis through pathology is crucial, especially for young children who face high mortality rates from complications like bronchopneumonia and multiple organ failure.

Area of Science:

  • Pediatric Pathology
  • Oncology
  • Dermatology

Context:

  • Langerhans cell hyperplasia (LCH) incidence is rising, presenting with varied clinical manifestations that frequently lead to misdiagnosis.
  • Accurate and timely diagnosis of LCH is challenging due to its diverse presentation across multiple organ systems.
  • Retrospective analysis of 44 LCH patients treated between 1990 and 2003 provides insights into clinical features and outcomes.

Purpose:

  • To analyze the clinical features of Langerhans cell hyperplasia (LCH) to improve early diagnosis and treatment strategies.
  • To highlight the diagnostic challenges and common misdiagnoses associated with LCH.
  • To identify risk factors and common complications in pediatric LCH cases.

Summary:

  • The study analyzed 44 LCH cases, with 72.7% being children, and 46.9% of these children under two years old.
  • Commonly involved organs included bone, lymph nodes, skin, liver, spleen, and lungs; 59.1% of patients were initially misdiagnosed.
  • Young children (<2 years) with LCH showed a high incidence of bronchopneumonia, sepsis, and multiple organ failure, contributing to a significant mortality rate.

Impact:

  • Emphasizes the critical role of pathology examination in the early diagnosis and effective management of LCH.
  • Highlights the need for increased clinical awareness of LCH, particularly in pediatric patients presenting with non-specific symptoms.
  • Findings underscore the importance of prompt diagnosis and treatment to prevent severe complications and reduce mortality in LCH.
Abstract

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...